Decreased expression of signal-transducing ζ chain in peripheral T cells and natural killer cells in patients with cervical cancer

Clinical Cancer Research

Volumn 2, Issue 11, 1996, Pages 1825-1828

  Kono, Koji ^a   Ressing, Maaike E ^b   Brandt, Remco M P ^b   Melief, Cornells J M ^b   Potkul, Ronald K ^c   Andersson, Birger ^d   Petersson, Max ^a   Kast, W Martin ^b,c   Kiessling, Rolf ^a,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

^d CALAB Medical Laboratories   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX DYSPLASIA;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; FEMALE; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTES, TUMOR-INFILTRATING; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IGG; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; UTERINE CERVICAL NEOPLASMS;

EID: 0029828089     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Mischer, S., Whiteside, T. L., Carrel, S., and von Fliedner, V. Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J. Immunol., 136: 1899-1907, 1986.
2. Matsuda, M., Salazar, F., Petersson, M., Masucci, G., Hansson, J., Pisa, P., Zhang, Q. J., Masucci, M. G., and Kiessling, R. Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA-class I expression. J. Exp. Med., 180: 2371-2376, 1994.
3. Fujii, T., Igarashi, T., and Kishimoto, S. Significance of suppressor macrophages for immune surveillance of tumor-bearing mice. J. Natl. Cancer Inst., 78: 509-517, 1987.
4. 2 la, and tumor necrosis factor-α, Immunopharmacology, 25: 215-227, 1993.
5. Irving, B. A., and Weiss, A. The cytoplasmic domain of the T cell receptor ζ chain is sufficient to couple to receptor-associated signal transduction pathways. Cell, 64: 891-901, 1991.
6. Mizoguchi, H., O'Shea, J. J., Longo, D. L , Loeffler, C. M., McVicar, D. W., and Ochoa, A. C. Alteration in signal transduction molecules in T-lymphocytes from tumor-bearing mice. Science (Washington DC), 258: 1795-1798, 1992.
7. Nakagomi, H., Petersson, M., Magnusson, I., Juhlin, C., Matsuda, M., Mellstedt, H., Taupin, J. L., Vivier, E., Anderson, P , and Kicssling, R. Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res., 53: 5610-5612, 1993.
8. Matsuda, M., Petersson, M., Lenkei, R., Taupin, J. L., Magnasson, I., Mellstedt, H., Anderson, P., and Kiessling, R. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. Int. J. Cancer, 61: 765-772, 1995.
9. lck in T-cells infiltrating human renal cell carcinoma. Cancer Res., 53: 5613-5616, 1993.
10. Tartour, E., Latour, S., Mathiot, C., Thiounn, N., Mosseri, V., Joyeux, I., D'Enghien, C. D., Lee, R., Debre, B., and Fridman, W. H. Variable expression of CD3 ζ chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. Int. J. Cancer, 63: 205-212. 1995.
11. Zea, A. H., Curti, B. D., Longo, C. D., Alvord, W. G., Srobl, S. L., Mizoguchi, H., Creekmore, S. P , O'Shea, J. J., Powers, G. C., Urba, W. J. and Ochoa, A. C. Alterations in T cell receptor and signal transduction molecules in melanoma patients. Clin. Cancer Res., 1: 1327-1335, 1995.
12. Lai, P., Rabinowich, H., Crowley-Nowick, P A., Bell, M. C., Mantovani, G., and Whiteside, T. L. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma. Clin. Cancer Res., 2: 161-173, 1996.
13. Gunji, Y., Hori, S., Aoe, T., Asano, T., Ochiai, T., Isono, K., and Saito, T. High frequency of cancer patients with abnormal assembly of the T cell receptor-CD3 complex in peripheral blood T lymphocytes. Jpn. J. Cancer Res., 85: 1189-1192, 1994.
14. Kono, K., Salazar, F., Petersson, M., Hansson, J., Masucci, G., Wasserman, K., Nakazawa, T., Anderson. P., and Kiessling, R. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and NK-mediated cytotoxicity. Eur. J. Immunol., in press, 1996.
15. Parkin, D M , Pisani, P., and Ferlay, J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer, 54: 594-606, 1993.
16. Zur Hausen, H. Human papillomavirus in the pathogenesis of anogenital cancer. Virology, 184: 9-13, 1991.
17. Anderson, P., Caligiuri, M., O'Brien, C., Manley, T., Ritz, J., and Schlossman, S. F. Fcγ receptor type III (CD16) is included in βNK receptor complex expressed by human natural killer cells. Proc. Natl. Acad Sci. USA, 87: 2274-2278, 1990.
18. Vivier, E., Rochet. N., Kochan, J. P., Presky, D. H., Schlossman, S. F., and Anderson, P. Structural similarity between Fc receptors and T-cell receptors. J. Immunol., 147: 4263-4270, 1991.
19. Hansen, M. B., Nielsen, S. E., and Berk, K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods, 119: 203-210, 1989.
20. Anderson, P., Caligiuri. M., O'Brien, C., Manley, T., Ritz, J., and Schlossman, S. F. Fcγ receptor type III (CD16) is included in ζNK receptor complex expressed by human natural killer cells. Proc. Natl. Acad. Sci USA, 87: 2274-2278, 1990.
21. Sussman, J. J., Bonifacio, J. S., Lippincott-Schwartz, J., Weissman, A. M., Saito, T., Klausner, R. D., and Ashwell, J. D. Failure to synthesize the T cell CD3-ζ chain: structure and function of a partial T cell receptor complex. Cell, 52: 85-95, 1988.
22. Ressing, M. E., van Driel, W. J., Celis, E., Sette, A., Brandt, R. M. P., Hartman, M., Anholts, J. D. H., Schreuder, G. M. T., ter Harmsel, W. B., Fleuren, G. J., Trimbos, B. J., Kast, W. M., and Melief, C. J. M. Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A 0201-restricted E7-encoded epitope. Cancer Res., 56: 582-588, 1996.
23. Aoe, T., Okamoto, Y., and Saito, T. Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex. J. Exp. Med., 181: 1881-1886, 1995.
24. Helistrand, K., Asea, A., Dahlgren, C., and Hermodsson, S. Histaminergic regulation of NK cells. Role of monocyte-derived reactive oxygen metabolites. J. Immunol., 153: 4940-4947, 1994.
25. Hansson, M., Asea, A., Ersson, U., Hermodsson, S., and Hellstrand, K. Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites J. Immunol., 156: 42-47, 1996.